S
Suding Zhu
Researcher at Anhui Medical University
Publications - 3
Citations - 8
Suding Zhu is an academic researcher from Anhui Medical University. The author has contributed to research in topics: Medicine & Cancer research. The author has co-authored 1 publications.
Papers
More filters
Journal ArticleDOI
N6-Methyladenosine RNA Modification: An Emerging Immunotherapeutic Approach to Turning Up Cold Tumors.
Lei Zhan,Junhui Zhang,Junhui Zhang,Suding Zhu,Xiaojing Liu,Jing Zhang,Wenyan Wang,Yijun Fan,Shiying Sun,Bing Wei,Yunxia Cao,Yunxia Cao +11 more
TL;DR: In this article, the role of m6A RNA modification in cold tumor formation and regulation is discussed, and the potential clinical implications and immunotherapeutic approaches of the modification in cancer patients are discussed.
Journal ArticleDOI
Roles of N6-methyladenosine (m6A) modifications in gynecologic cancers: mechanisms and therapeutic targeting
Jia-Hua Chen,Bao Guo,Xiaojing Liu,Jing Zhang,Junhui Zhang,Yuan Fang,Suding Zhu,Bing Wei,Yunxia Cao,Lei Zhang +9 more
TL;DR: In this article , the role of m 6 A in gynecologic cancers is discussed and a review of the recent advancements in m 6A modification is presented to improve the understanding of the occurrence, diagnosis, treatment, and prognosis of gynecological cancers.
Journal ArticleDOI
NLRC5 Might Promote Endometrial Cancer Progression by Inducing PD-L1 Expression
Suding Zhu,Jin Zhang,Xiaojing Liu,Jun Hui Zhang,Bing Wei,Wenyan Wang,Yidan Fan,Dan Li,Yunxia Cao,Lei Zhang +9 more
TL;DR: NLRC5 could inhibit the activation of PD-L1 in EC and mutations of ANKRD20A2, C2orf42, ADGRB3, AVPR2, GOLGA6C, and IPPK may lead to the downregulation of NLRC5 in EC patients.